Related Experiment Video
Updated: Mar 19, 2026
07:25
Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
9.0K
Erratum: The relationship between dopamine receptor D1 and cognitive performance.
NPJ Schizophrenia
|June 24, 2016
Summary
This study corrects the article DOI for a previous publication. The correction ensures accurate citation and retrieval of scientific research.
Area of Science:
- Bibliometrics
- Scientific Publishing
- Schizophrenia Research
Context:
- Accurate citation is crucial for scientific integrity.
- Digital Object Identifiers (DOIs) are essential for locating research articles.
- Previous publications may contain errors requiring correction.
Purpose:
- To correct an erroneous DOI associated with a published article.
- To ensure researchers can accurately access and cite the intended study.
- To maintain the integrity of the scientific record.
Summary:
- This entry serves as a correction notice.
- It rectifies the Digital Object Identifier (DOI) for a specific article.
- The correction facilitates proper referencing and access to the research.
Impact:
- Improves the accuracy of scientific literature databases.
- Ensures reliable access to research for the scientific community.
- Upholds standards of precision in academic publishing.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
804
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
804
01:30Attention-Deficit/Hyperactivity Disorder
1.3K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
01:29Drugs Affecting Neurotransmitter Synthesis
2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K